Skip to Main Content

Paper Details

Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross.
G3 (Bethesda)
31
2017
Collaborative Cross, F1, F1 hybrids, Oas, Oas1b, Oas1b allele, Oas1b gene, Oas1b haplotype, WNV, WSB, West Nile Virus, West Nile virus, flavivirus, founder strains, full-length OAS1B protein, mice, mouse, novel innate immune gene signatures, oligoadenylate-synthetase, oligoadenylate-synthetase (Oas) gene locus, wild-derived inbred founder strains, wild-type Oas1b
2',5'-Oligoadenylate Synthetase, Animals, Disease Models, Animal, Disease Susceptibility, Gene Expression Profiling, Host-Pathogen Interactions, Immunity, Innate, Immunomodulation, Male, Mice, Quantitative Trait Loci, Transcription, Genetic, Transcriptome, West Nile Fever, West Nile virus
Author NameAffiliation
Richard GreenUniversity of Washington
Richard GreenCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Courtney WilkinsUniversity of Washington
Courtney WilkinsCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Sunil ThomasUniversity of Washington
Sunil ThomasCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Aimee SekineUniversity of Washington
Aimee SekineCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Duncan HendrickUniversity of Washington
Duncan HendrickCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Kathleen M VossUniversity of Washington
Kathleen M VossCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Renee C IretonUniversity of Washington
Renee C IretonCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Michael A MooneyOHSU Knight Cancer Institute, Oregon Health & Science University
Michael A MooneyDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University
Jennifer Tisoncik-GoUniversity of Washington
Jennifer Tisoncik-GoCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
Gabrielle ChoonooOHSU Knight Cancer Institute, Oregon Health & Science University
Gabrielle ChoonooDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University
Sophia JengOregon Clinical and Translational Research Institute, Oregon Health & Science University
Fernando Pardo-Manuel de VillenaUniversity of North Carolina at Chapel Hill
Fernando Pardo-Manuel de VillenaLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Fernando Pardo-Manuel de VillenaUniversity of North Carolina at Chapel Hill
Fernando Pardo-Manuel de VillenaLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Martin T FerrisUniversity of North Carolina at Chapel Hill
Martin T FerrisUniversity of North Carolina at Chapel Hill
Shannon K McWeeneyOHSU Knight Cancer Institute, Oregon Health & Science University
Shannon K McWeeneyDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University
Shannon K McWeeneyOregon Clinical and Translational Research Institute, Oregon Health & Science University
Michael GaleUniversity of Washington
Michael GaleCenter for Innate Immunity and Immune Disease (CIIID), University of Washington
  • 1 - 32

Datasets